From the Research
Monjarou does not cause acute kidney injury (AKI) based on the available evidence. The provided studies do not specifically mention Monjarou as a cause of AKI. However, it is essential to consider the potential risks of herbal remedies, as discussed in studies such as 1 and 2, which highlight the importance of monitoring patients with pre-existing kidney disease and being aware of potential interactions with other medications.
Key Points to Consider
- The studies provided do not directly link Monjarou to AKI, but they do emphasize the importance of awareness and monitoring in patients with kidney disease.
- Herbal remedies, in general, can pose health risks, including kidney damage, as noted in 1 and 2.
- Patients with severe gastrointestinal side effects from any medication, including Monjarou, could potentially develop dehydration leading to prerenal AKI if not properly managed, as suggested by the general principles of managing AKI discussed in 3 and 4.
- The most recent and highest quality study on AKI, 4, focuses on the global concern of AKI, its diverse pathophysiological mechanisms, and the importance of prevention and early detection, but does not specifically mention Monjarou.
- Given the lack of direct evidence linking Monjarou to AKI and considering the potential benefits of improving glycemic control and reducing obesity, it is crucial for patients taking Monjarou to stay adequately hydrated, especially if experiencing gastrointestinal side effects, and for those with pre-existing kidney disease to be monitored.